MK0476 Study in Adult Patients With Acute Asthma (0476-322)

• Status: Completed
• Trial end date: 2007-06-01
• Target enrollment: 0
• Participant gender: All

Summary

This study evaluates the efficacy and safety of MK0476 intravenous administration in adult patients with acute asthma.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.
• Treatments: Montelukast

Criteria

Inclusion Criteria:

• Adult Patients With Acute Asthma Attacks

Exclusion Criteria:

• Patient Has Any Known Or Suspected, Acute Or Chronic Cause For Their Pulmonary Symptoms Other Than Asthma (E.G., Copd, Chronic Heart Failure, Etc.)

• Patient Has A Smoking History (20 Cigarettes Per Day) Of More Than 15 Years

• Patient Has A Disease Of The Cardiovascular, Hepatic, Renal, Hematologic Systems, Or Other Severe Disease